Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
about
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Development and Internal Valid ...... al Relapse in Crohn's Disease.
@en
Development and Internal Valid ...... al Relapse in Crohn's Disease.
@nl
type
label
Development and Internal Valid ...... al Relapse in Crohn's Disease.
@en
Development and Internal Valid ...... al Relapse in Crohn's Disease.
@nl
prefLabel
Development and Internal Valid ...... al Relapse in Crohn's Disease.
@en
Development and Internal Valid ...... al Relapse in Crohn's Disease.
@nl
P2093
P2860
P50
P1476
Development and Internal Valid ...... cal Relapse in Crohn's Disease
@en
P2093
Camille Jarlot
Emilie Del Tedesco
Gerard Duru
Jean Marc Phelip
Laurent Peyrin-Biroulet
Murielle Cuilleron
Nicolas Williet
P2860
P304
P356
10.1097/MIB.0000000000000986
P577
2017-01-01T00:00:00Z